How changes in human DNA can influence response to drug treatments
DNAVision, a leading global provider of pharmacogenetic services, helps pharmaceutical companies and clinical research organizations (CROs) effectively integrate pharmacogenetics into their drug development program and also into the field of personal medicine.
DNAVision is able to provide a complete range of pharmacogenetic services using their powerful combination of sequencing platforms.
We guarantee the quality of our results by complying with the international standards required by regulatory authorities. DNAVision is the first laboratory in Europe to be ISO17025 accredited for pharmacogenetics and pharmacogenomics tests. We are also CLIA and CAP accredited.